323 related articles for article (PubMed ID: 30576338)
1. The downregulation of lncRNA EMX2OS might independently predict shorter recurrence-free survival of classical papillary thyroid cancer.
Gu Y; Feng C; Liu T; Zhang B; Yang L
PLoS One; 2018; 13(12):e0209338. PubMed ID: 30576338
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatic analysis of the prognostic value and potential regulatory network of FOXF1 in papillary thyroid cancer.
Gu Y; Hu C
Biofactors; 2019 Nov; 45(6):902-911. PubMed ID: 31498939
[TBL] [Abstract][Full Text] [Related]
3. Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer.
Gong Y; Yang J; Wu W; Liu F; Su A; Li Z; Zhu J; Wei T
PLoS One; 2018; 13(5):e0197007. PubMed ID: 29723302
[TBL] [Abstract][Full Text] [Related]
4. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
Pang R; Yang S
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
[TBL] [Abstract][Full Text] [Related]
5.
Luo J; Zhang B; Cui L; Liu T; Gu Y
Future Oncol; 2019 Apr; 15(12):1303-1311. PubMed ID: 30757917
[No Abstract] [Full Text] [Related]
6. Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer.
Zhao Y; Wang H; Wu C; Yan M; Wu H; Wang J; Yang X; Shao Q
Oncol Rep; 2018 Mar; 39(3):1197-1206. PubMed ID: 29328463
[TBL] [Abstract][Full Text] [Related]
7. EMX2OS plays a prognosis-associated enhancer RNA role in gastric cancer.
Liu GX; Tan YZ; He GC; Zhang QL; Liu P
Medicine (Baltimore); 2021 Oct; 100(41):e27535. PubMed ID: 34731149
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance.
Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H
Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Emx2 expression by antisense transcripts in murine cortico-cerebral precursors.
Spigoni G; Gedressi C; Mallamaci A
PLoS One; 2010 Jan; 5(1):e8658. PubMed ID: 20066053
[TBL] [Abstract][Full Text] [Related]
10. LncRNA ENST00000539653 acts as an oncogenic factor via MAPK signalling in papillary thyroid cancer.
Song B; Li R; Zuo Z; Tan J; Liu L; Ding D; Lu Y; Hou D
BMC Cancer; 2019 Apr; 19(1):297. PubMed ID: 30940124
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of serum lncRNA-ABHD11-AS1 as poor prognosis of patients with papillary thyroid carcinoma.
Hou S; Zhuang YY; Lin QY; Chen Z; Zhao HG; Zhang L; Lin CH
Exp Mol Pathol; 2021 Aug; 121():104658. PubMed ID: 34102210
[TBL] [Abstract][Full Text] [Related]
12. Antisense transcripts at the EMX2 locus in human and mouse.
Noonan FC; Goodfellow PJ; Staloch LJ; Mutch DG; Simon TC
Genomics; 2003 Jan; 81(1):58-66. PubMed ID: 12573261
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis identifying new lncRNA markers revealed in ceRNA network for tumor recurrence in papillary thyroid carcinoma and build of nomogram.
Chen F; Li Z; Deng C; Yan H
J Cell Biochem; 2019 Dec; 120(12):19673-19683. PubMed ID: 31271223
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.
Feng Z; Chen R; Huang N; Luo C
Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
[TBL] [Abstract][Full Text] [Related]
15. A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer.
Xi ZH; Ma XX; Chen HY; Yu YH; Li L; Huang T
Curr Med Sci; 2021 Oct; 41(5):1004-1011. PubMed ID: 34510328
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma.
Jiang H; Chen H; Wan P; Song S; Chen N
Aging (Albany NY); 2020 Nov; 12(24):25865-25877. PubMed ID: 33234727
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer.
Li Q; Li H; Zhang L; Zhang C; Yan W; Wang C
Oncotarget; 2017 Jul; 8(28):46136-46144. PubMed ID: 28545026
[TBL] [Abstract][Full Text] [Related]
18. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
Zhao H; Li H
Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265
[TBL] [Abstract][Full Text] [Related]
19. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
20. Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer.
Wang Q; Yang H; Wu L; Yao J; Meng X; Jiang H; Xiao C; Wu F
Thyroid; 2016 Dec; 26(12):1719-1732. PubMed ID: 27758138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]